Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway.
about
Adverse effect of high glucose concentration on stem cell therapyEndothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?Ambient particulate matter exposure and cardiovascular diseases: a focus on progenitor and stem cellsFibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan CrosstalkAdiponectin as a potential biomarker of vascular diseaseDevelopmental and pathological angiogenesis in the central nervous systemN-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic ratsImage-guided pro-angiogenic therapy in diabetic stroke mouse models using a multi-modal nanoprobe.Detemir plus aspart and glulisine induced lipoatrophy: 2015 literature review and report of a new caseRole of redox environment on the oligomerization of higher molecular weight adiponectin.Adiponectin provides cardiovascular protection in metabolic syndrome.Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated type 1 diabetes.Ambient Fine Particulate Matter Suppresses In Vivo Proliferation of Bone Marrow Stem Cells through Reactive Oxygen Species Formation.Adiponectin and cardiovascular health: an updateMelatonin reverses H2 O2 -induced premature senescence in mesenchymal stem cells via the SIRT1-dependent pathway.Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 PhosphorylationAdiponectin regulates bone marrow mesenchymal stem cell niche through a unique signal transduction pathway: an approach for treating bone disease in diabetesBone marrow-derived Kruppel-like factor 10 controls reendothelialization in response to arterial injury.Cell-based therapies for diabetic retinopathy.Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease.Strategies to reverse endothelial progenitor cell dysfunction in diabetesAdipokines and the cardiovascular system: mechanisms mediating health and disease.Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction.Adiponectin: mechanisms and new therapeutic approaches for restoring diabetic heart sensitivity to ischemic post-conditioning.Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder.Adiponectin induces CXCL1 secretion from cancer cells and promotes tumor angiogenesis by inducing stromal fibroblast senescence.A Clinical Perspective: Contribution of Dysfunctional Perivascular Adipose Tissue (PVAT) to Cardiovascular Risk.The Role of Adipocytokines in Coronary Atherosclerosis.Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes.Adiponectin attenuates liver fibrosis by inducing nitric oxide production of hepatic stellate cells.Heme oxygenase-2/adiponectin protein-protein interaction in metabolic syndrome.The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells.Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.Uremia induces functional incompetence of bone marrow-derived stromal cells.Cleaved high-molecular-weight kininogen accelerates the onset of endothelial progenitor cell senescence by induction of reactive oxygen species.Accelerated fat cell aging links oxidative stress and insulin resistance in adipocytes.Impact of serum source and inflammatory cytokines on the isolation of endothelial colony-forming cells from peripheral blood.A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade.Constitutive Expression of Adiponectin in Endothelial Progenitor Cells Protects a Rat Model of Cerebral Ischemia.The role of β-adrenergic receptors and p38MAPK signaling pathways in physiological processes of cardiosphere-derived cells.
P2860
Q24609292-4D1FB9BA-ACD1-47DF-8F8D-1E3E7ADCA01BQ26745523-83194B4A-ABA9-4CB2-AF7B-1B7E2D93F938Q26764744-27322F82-223D-4D03-8AE8-7166CEA60EC3Q26766528-B1C9006E-61ED-4932-8465-A3459245A808Q26821925-0BC9F9F2-3DE2-45E9-B5DB-4B6DEAD90483Q27023250-1F07BD65-2D4F-4486-B36D-D5E2828AD5F3Q28476775-149ADF90-CC3C-45B1-9216-D4E65BAAB3AEQ33779819-7CE211DF-9509-4C7E-BA4E-A1129746383BQ33801219-2A3D7598-A95C-473C-BE09-F0E8E5B2E2C3Q33907318-871B2009-EF25-4AF2-9418-0050FD935F8FQ34557564-ACB42A3D-92CB-484C-AAB5-65833DFA9714Q35415607-105DE8D8-4AE2-4C00-853D-82045459F62BQ35658522-8F5DF43B-2691-4516-B249-B81A7E2C5BABQ35859734-ACE94071-8759-46C9-92E3-A82CC28D169EQ35912226-ED596BC8-48C5-4D73-A98B-66D2C09202C0Q35914331-3422EB62-206D-4C30-97CA-7D7D85E70BD9Q36377482-1833097B-3C9F-4853-B33C-F603088112C0Q37328461-5FBE2BEC-641E-4612-9D62-5DD997F86FFAQ37879584-082553C7-5B50-4826-9A7C-DFD86F48A569Q37972596-5D43B69B-7459-4B3B-B7D3-DF48BEE90588Q37999783-F868F374-9912-4109-B95F-5CE9161439DAQ38014474-AEAA9831-B782-42D8-98A9-77FFEFA824A9Q38071250-7F0F6DDC-9E7D-4AE0-A1AD-8A948FFF05F0Q38125624-E1E515D4-87CE-4C7F-88BB-16C78C9A4CEAQ38599441-6DF86AEF-0AA7-4D1D-99A5-28DB9CA67C13Q38777200-5A391D14-2FB2-453C-B71A-2FC8800048A5Q38992651-33D1BBBB-87B4-4BBA-B0E3-7E4F7D823F9CQ39129323-07E98CF0-1D36-4C9A-825E-D05EC33BFE08Q40025985-8C3D6692-0260-4BDC-9BA5-771E5680A080Q40759563-07380759-7245-4C0C-90F5-487ADB47CBD6Q41361078-E2E63EF1-79B8-4557-920C-472F1E26E497Q41547499-7139D966-4C02-4CD8-8911-577701BB5F9BQ42145401-2DBB0684-990E-44C0-9783-BDFA62BAE260Q42489157-2DDBFB66-058D-476F-8300-0982AAF7D4BAQ42728764-AC504E68-6B74-4B37-B918-97F9412E1A45Q42825832-EC4FF818-303F-43D8-9D30-682048A75394Q44339465-1B9ABBA0-6ADD-4F22-835F-1C4719799829Q44571740-8C9371DB-C86F-4D33-BF31-677D9FF0BB50Q47187722-112149D9-471E-4F89-A124-250BAEF63CFDQ48103647-22F39AFE-6B42-4C8E-8134-DF68AF514703
P2860
Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Adiponectin prevents diabetic ...... se/p16INK4A signaling pathway.
@ast
Adiponectin prevents diabetic ...... se/p16INK4A signaling pathway.
@en
Adiponectin prevents diabetic ...... se/p16INK4A signaling pathway.
@nl
type
label
Adiponectin prevents diabetic ...... se/p16INK4A signaling pathway.
@ast
Adiponectin prevents diabetic ...... se/p16INK4A signaling pathway.
@en
Adiponectin prevents diabetic ...... se/p16INK4A signaling pathway.
@nl
prefLabel
Adiponectin prevents diabetic ...... se/p16INK4A signaling pathway.
@ast
Adiponectin prevents diabetic ...... se/p16INK4A signaling pathway.
@en
Adiponectin prevents diabetic ...... se/p16INK4A signaling pathway.
@nl
P2093
P2860
P50
P356
P1433
P1476
Adiponectin prevents diabetic ...... ase/p16INK4A signaling pathway
@en
P2093
Junlei Chang
Karen S L Lam
Paul M Vanhoutte
Ruby L C Hoo
P2860
P304
P356
10.2337/DB10-0582
P407
P577
2010-08-29T00:00:00Z